Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of paeonol acetic acid compound, its preparation method and medical application

A technology of paeonol acetic acid and compound, which is applied in the fields of medicinal chemistry and pharmacotherapeutics, and can solve the problems of easy volatility, easy metabolism, poor water solubility, limited clinical application and the like

Active Publication Date: 2019-04-16
ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Paeonol has great potential in the prevention and treatment of cardiovascular and cerebrovascular diseases, but its clinical application is limited due to its volatility, easy metabolism and poor water solubility.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of paeonol acetic acid compound, its preparation method and medical application
  • A kind of paeonol acetic acid compound, its preparation method and medical application
  • A kind of paeonol acetic acid compound, its preparation method and medical application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0122] Preparation of paeonol acetic acid (2)

[0123]Put paeonol (1.0g, 6.0mmol), sodium hydroxide (1.5g, 37.5mmol), and appropriate amount of DMF in a 100mL round bottom flask, and stir at room temperature for 20min. Bromoacetic acid (1.5 g, 10.8 mmol) was added with stirring, and the progress of the reaction was monitored by TLC. After the reaction was complete, the reaction solution was poured into 100 mL of water, adjusted to pH 2 with hydrochloric acid, and extracted with ethyl acetate (30 mL*3). The organic layer was washed with saturated NaCl solution, anhydrous Na 2 SO 4 After drying, filter. The filtrate was concentrated under reduced pressure, and column chromatography (methanol:dichloromethane=1:20) gave 1.1 g of white solid, yield 81%.

[0124] Preparation of Paeonol Acetate-2-Bromoethyl Ester (3)

[0125] Weigh 2.0g (8.9mmol) paeonol acetic acid in a 50mL round bottom flask, add 10ml DMF to dissolve. Join K 2 CO 3 (1.8g, 13.4mmol), after stirring for five...

Embodiment 2

[0129] The method for preparing paeonol acetic acid with reference to embodiment 1.

[0130] Preparation of Paeonol Acetate-3-Bromopropyl Ester (3)

[0131] Weigh 2.0g (8.9mmol) paeonol acetic acid in a 50mL round bottom flask, add 10ml DMF to dissolve. Join K 2 CO 3 (1.8g, 13.4mmol), after stirring for five minutes, 1,3-dibromopropane (2.8ml, 26.7mmol) was added, and the reaction progress was monitored by TLC. After 2 hours of reaction, the reaction solution was poured into 100 mL of water, extracted with dichloromethane (50 mL×3), the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (ethyl acetate:petroleum ether (v: v)=1:4) to obtain 2.5 g of white solid, with a yield of 81.4%.

[0132] Paeonol acetate-3-(1-piperidinyl)propyl ester (I 8 ) preparation

[0133] Weigh 2.0g (5.8mmol) paeonol acetate-3-bromopropyl acetate, piperidine (1.7mL, 17.4mmol) in a 50mL round bottom flask, add 1...

Embodiment 3

[0135] The method for preparing paeonol acetic acid with reference to embodiment 1.

[0136] Preparation of 4-bromobutyl paeonol acetate (3)

[0137] Weigh 2.0g (8.9mmol) paeonol acetic acid in a 50mL round bottom flask, add 10ml DMF to dissolve. Join K 2 CO 3 (1.8g, 13.4mmol), after stirring for five minutes, 1,4-dibromobutane (3.2ml, 26.7mmol) was added, and the reaction progress was monitored by TLC. After 2 hours of reaction, the reaction solution was poured into 100 mL of water, extracted with dichloromethane (50 mL×3), the organic phase was washed with saturated brine, dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography (ethyl acetate:petroleum ether (v: v)=1:4) to obtain 2.6 g of white solid, yield 81.3%.

[0138] Paeonol acetate-4-[(4-methyl)-1-piperazinyl]butyl ester (I 17 ) preparation

[0139] Weigh 2.0g (5.6mmol) of 4-bromobutyl paeonol acetate and N-methylpiperazine (1.8ml, 16.2mmol) into a 50mL round bottom flask, add 1...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of pharmaceutical chemistry and pharmacotherapeutics, and particularly relates to a paeonol acetic acid compound as well as a preparation method and application thereof to pharmacy. The compound has an effect of platelet aggregation resistance, and can be used for preparing a medicine for treating cardiovascular and cerebrovascular diseases. The invention also relates to the preparation method of the compound.

Description

technical field [0001] The invention relates to the fields of medicinal chemistry and pharmacotherapeutics, in particular to paeonol acetic acid compounds. The compounds have the effect of anti-platelet aggregation, and can be used to prepare drugs for preventing and treating cardiovascular and cerebrovascular diseases, such as anti-platelet drugs, antithrombotic drugs, blood lipid-lowering drugs, and anti-atherosclerosis drugs. The invention also relates to processes for the preparation of such compounds. Background technique [0002] Cardiovascular and cerebrovascular diseases cause extremely serious harm to health, such as coronary heart disease, cerebral thrombosis, atherosclerosis, etc., have become the main diseases that threaten human health. Thromboembolic disease is closely related to the pathogenesis of cardiovascular and cerebrovascular diseases, and has become one of the diseases that mainly endanger human health. Its incidence rate ranks first among all kinds o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D295/088A61K31/4453A61K31/495A61P7/02A61P9/10A61P3/06
CPCC07D295/088
Inventor 何黎琴柏志伟聂小琴
Owner ANHUI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE